www.hivandhepatitis.com

Back HCV Treatment

EASL 2009: Antiviral Agents with Activity against Both HIV and Hepatitis C Virus

Details
Category: Experimental HCV Drugs
Published on Tuesday, 02 June 2009 13:47
Written by Liz Highleyman
  • Print

Standard therapy for chronic hepatitis C virus (HCV) infection consists of pegylated interferon plus ribavirin, but several novel agents under study directly target various steps of the HCV lifecycle, an approach known as "STAT-C." Some of these investigational agents work similarly to certain antiretroviral drugs for HIV, suggesting it may be possible to develop drugs that have activity against both HIV-HCV, a potential benefit for HIV-HCV coinfected patients.

Read more:

Subcategories

Copyright © 2026 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design